Literature DB >> 15459135

Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture.

O Holz1, I Zühlke, E Jaksztat, K C Müller, L Welker, M Nakashima, K D Diemel, D Branscheid, H Magnussen, R A Jörres.   

Abstract

Emphysema is characterised by a loss of alveolar structure, as reflected in elastic recoil and gas exchange. As fibroblasts play a key role in the maintenance of structure, the current authors hypothesised that their proliferation might be constitutively impaired in lung emphysema. Using explant cultures, lung fibroblasts were obtained from resected lungs of 10 patients with emphysema (median forced expiratory volume in one second (FEV1) 40% predicted) and 10 control patients (FEV1, 95% pred). The doubling time (DT) was measured over 4 days under standard conditions (10% foetal calf serum) prior and after cryopreservation. Additionally, in seven samples per group the total population doubling level (PDL) was determined. In emphysema, mean+/-sem DT was 33.6+/-2.8 h compared with 24.8+/-1.4 h in controls. The differences in DT were preserved after cryopreservation. Groups also differed in the initial slope of the PDL plot during long-term culture (up to 35 days). However, the median (range) maximum PDL did not differ significantly between groups (13.8 (7.4-22.6) versus 20.2 (11.2-25.5)). The current authors, therefore, suggest that the reduced proliferation rate in vitro of lung fibroblasts from patients with emphysema reflects a persistent, intrinsic failure of cellular replacement and maintenance in this disease, possibly in relation to pre-term aging.

Entities:  

Mesh:

Year:  2004        PMID: 15459135     DOI: 10.1183/09031936.04.00143703

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  58 in total

1.  Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts.

Authors:  Masanori Nakanishi; Tadashi Sato; Yingji Li; Amy J Nelson; Maha Farid; Joel Michalski; Nobuhiro Kanaji; Xingqi Wang; Hesham Basma; Amol Patil; Jadvinder Goraya; Xiangde Liu; Shinsaku Togo; Myron L Toews; Olaf Holz; Kai-Christian Muller; Helgo Magnussen; Stephen I Rennard
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02       Impact factor: 6.914

Review 2.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

Review 3.  Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema.

Authors:  Stephen I Rennard; Shinsaku Togo; Olaf Holz
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 4.  Cellular senescence in normal and premature lung aging.

Authors:  B Bartling
Journal:  Z Gerontol Geriatr       Date:  2013-10       Impact factor: 1.281

Review 5.  Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung.

Authors:  Toru Nyunoya; Yohannes Mebratu; Amelia Contreras; Monica Delgado; Hitendra S Chand; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

6.  Decreased proteasomal function accelerates cigarette smoke-induced pulmonary emphysema in mice.

Authors:  Yosuke Yamada; Utano Tomaru; Akihiro Ishizu; Tomoki Ito; Takayuki Kiuchi; Ayako Ono; Syota Miyajima; Katsura Nagai; Tsunehito Higashi; Yoshihiro Matsuno; Hirotoshi Dosaka-Akita; Masaharu Nishimura; Soichi Miwa; Masanori Kasahara
Journal:  Lab Invest       Date:  2015-04-27       Impact factor: 5.662

7.  Pentagalloyl glucose increases elastin deposition, decreases reactive oxygen species and matrix metalloproteinase activity in pulmonary fibroblasts under inflammatory conditions.

Authors:  Vaideesh Parasaram; Nasim Nosoudi; Aniqa Chowdhury; Naren Vyavahare
Journal:  Biochem Biophys Res Commun       Date:  2018-03-19       Impact factor: 3.575

Review 8.  Influencing the decline of lung function in COPD: use of pharmacotherapy.

Authors:  Ekaterina S Gladysheva; Atul Malhotra; Robert L Owens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

9.  Caveolin-1, cellular senescence and pulmonary emphysema.

Authors:  Daniela Volonte; Ferruccio Galbiati
Journal:  Aging (Albany NY)       Date:  2009-08-10       Impact factor: 5.682

10.  Altered fibroblast proteoglycan production in COPD.

Authors:  Oskar Hallgren; Kristian Nihlberg; Magnus Dahlbäck; Leif Bjermer; Leif T Eriksson; Jonas S Erjefält; Claes-Göran Löfdahl; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2010-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.